Patents by Inventor Vera Holländer
Vera Holländer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11542494Abstract: The present invention pertains to a method for isolating a target nucleic acid including small target nucleic acids from a sample, said method comprising at least the following steps a) binding at least a portion of the target nucleic acid including small target nucleic acids to a nucleic acid binding solid phase comprised in a column by passing the sample through said column, b) performing an enzymatic and/or chemical treatment on the nucleic acid binding solid phase while the target nucleic acid is bound to said solid phase, c) collecting at least a portion of the small target nucleic acids released from the solid phase during said treatment of step b) as flow-through, d) contacting said flow-through which comprises small target nucleic acids mixed with a recovery solution with a nucleic acid binding solid phase for binding the contained small target nucleic acids to said nucleic acid binding solid phase, e) optionally performing an elution.Type: GrantFiled: September 2, 2011Date of Patent: January 3, 2023Assignee: QIAGEN GmbHInventors: Vera Holländer, Gabriele Christoffel, Martin Schlumpberger
-
Patent number: 10514330Abstract: The present invention refers to a device, comprising a hollow body having at least one open end comprising at least one solid matrix binding, adsorbing, absorbing, chelating or retaining compounds which are not desired in a sample and preferably at least one barrier which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force to the barrier, the use of such a device for isolating or purifying a biomolecule from a sample, a method for preparation of the device and a method for isolation or purification of any biomolecule using said device.Type: GrantFiled: July 13, 2011Date of Patent: December 24, 2019Assignee: QIAGEN GmbHInventors: Vera Holländer, Markus Müller, Karin Schulte
-
Patent number: 10329553Abstract: The present invention provides a method for isolating RNA including small RNA having a size of 200 nt or less from a sample, comprising the following steps: a) providing a composition comprising RNA and a chaotropic agent; b) adding alcohol; c) incubating the mixture for at least 2 min; d) adding additional alcohol to the mixture to adjust the overall alcohol concentration in the mixture to ?50%; e) binding RNA contained in the mixture to a nucleic acid binding solid phase; f) optionally washing the bound RNA; g) optionally eluting RNA from the solid phase. Due to the step-wise addition of alcohol, the overall RNA yield and the yield of small RNA is improved.Type: GrantFiled: September 3, 2013Date of Patent: June 25, 2019Assignee: QIAGEN GmbHInventors: Martin Schlumpberger, Stefanie Schröer, Vera Holländer
-
Patent number: 10273470Abstract: The present invention pertains to a method for isolating RNA, including small RNA from a RNA and DNA containing sample, wherein the sample is lysed and the optionally further processed lysate is incubated with a DNase to degrade DNA prior to purifying the RNA from the optionally further processed lysate. It was found that performing the DNase digest prior to isolating the RNA from the lysate has considerable advantages.Type: GrantFiled: February 25, 2011Date of Patent: April 30, 2019Assignee: QIAGEN GmbHInventors: Vera Holländer, Gabriele Christoffel
-
Patent number: 10094749Abstract: The present invention refers to a device, comprising a hollow body having at least one open end and at least one barrier inside or at the end of the hollow body, which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force like pressure, drag force or driving power to said barrier, the use of such a device for collection, storage, treatment or isolation of a biomolecule or biomolecules containing samples, a method for preparation of said device and a method for isolation or purification of any biomolecules using said device.Type: GrantFiled: July 13, 2011Date of Patent: October 9, 2018Assignee: QIAGEN GmbHInventors: Margit Hiesinger, Vera Holländer, Markus Müller, Karin Schulte, Andre Schrader
-
Patent number: 10011826Abstract: The present invention relates to a method of isolating/extracting in parallel various biomolecules, in particular nucleic acids and proteins, from the same fixed biological samples, to the quantification and analysis of the biomolecules isolated by the method of the invention, and to a kit for isolating/extracting in parallel various biomolecules from a fixed sample, to the use of said kit for diagnosing, prognosing, deciding the therapy of and monitoring the therapy of a disease.Type: GrantFiled: December 4, 2009Date of Patent: July 3, 2018Assignee: QIAGEN GmbHInventors: Vera Holländer, Peter Porschewski
-
Patent number: 9422542Abstract: The present invention relates to a process for the parallel isolation and/or purification of RNA and DNA from the same fixed biological sample, the quantification and analysis of the nucleic acids isolated by the process according to the invention, to a kit for the parallel isolation and/or purification of RNA and DNA from a fixed sample and to the use of this kit for the diagnosis, prognosis, decision with respect to therapy and/or the monitoring of the therapy of a disease.Type: GrantFiled: February 25, 2011Date of Patent: August 23, 2016Assignee: Qiagen GmbHInventor: Vera Holländer
-
Publication number: 20150232831Abstract: The present invention provides a method for isolating RNA including small RNA having a size of 200 nt or less from a sample, comprising the following steps: a) providing a composition comprising RNA and a chaotropic agent; b) adding alcohol; c) incubating the mixture for at least 2 min; d) adding additional alcohol to the mixture to adjust the overall alcohol concentration in the mixture to ?50%; e) binding RNA contained in the mixture to a nucleic acid binding solid phase; f) optionally washing the bound RNA; g) optionally eluting RNA from the solid phase. Due to the step-wise addition of alcohol, the overall RNA yield and the yield of small RNA is improved.Type: ApplicationFiled: September 3, 2013Publication date: August 20, 2015Applicant: QIAGEN GmbHInventors: Martin Schlumpberger, Stefanie Schröer, Vera Holländer
-
Patent number: 9029138Abstract: The present invention provides a method for fixing and/or stabilizing a sample, in which the sample is put into a permeable container, the permeable container having an opening, which is pressed into the sample, then a portion of the sample brought into the permeable container in this way is separated from the rest of the sample, and the container filled with the sample in this way is immersed in fixing and/or stabilizing agents and the sample is fixed and/or stabilized.Type: GrantFiled: August 1, 2008Date of Patent: May 12, 2015Assignee: Preanalytix GmbHInventors: Daniel Groelz, Christian Lenz, Vera Hollaender, Thomas Rothmann
-
Patent number: 8796028Abstract: The invention relates to a method for treating a biological sample, comprising the following method steps: i) preparation of a biological sample and ii) bringing the biological sample into contact with a composition, comprising: (1) 1 to 100 wt. % of at least one polyol and (2) 0 to 99 wt. % of at least one additive, wherein the total amount of components (1) and (2) is 100 wt. %. The invention further relates to biological samples obtained by said method, a method for analysis of a treated biological sample, devices for treating a biological sample, use of said devices, various kits and use of a composition.Type: GrantFiled: December 29, 2006Date of Patent: August 5, 2014Assignee: Qiagen GmbHInventor: Vera Holländer
-
Patent number: 8673241Abstract: The present invention provides a method for fixing and/or stabilizing a sample, in which the sample is put into a permeable container with a maximum overall height of 10 mm, preferably of 5 mm, and the container filled with the sample is immersed in fixing and/or stabilizing agents and the sample is fixed and/or stabilized.Type: GrantFiled: August 1, 2008Date of Patent: March 18, 2014Assignee: Qiagen GmbHInventors: Daniel Groelz, Christian Lenz, Vera Hollaender, Thomas Rothmann
-
Publication number: 20130231460Abstract: The present invention relates to a method for concentrating one or more target compounds in a liquid sample, a device for carrying out this method and a kit for processing a biological sample comprising such a device.Type: ApplicationFiled: September 7, 2011Publication date: September 5, 2013Applicant: Qiagen GmbHInventors: Christoph Erbacher, Vera Holländer, Markus Müller, Martin Schlumpberger, Marion Schmidt, Markus Sprenger-Haussels
-
Publication number: 20130164825Abstract: The present invention pertains to a method for isolating a target nucleic acid including small target nucleic acids from a sample, said method comprising at least the following steps a) binding at least a portion of the target nucleic acid including small target nucleic acids to a nucleic acid binding solid phase comprised in a column by passing the sample through said column, b) performing an enzymatic and/or chemical treatment on the nucleic acid binding solid phase while the target nucleic acid is bound to said solid phase, c) collecting at least a portion of the small target nucleic acids released from the solid phase during said treatment of step b) as flow-through, d) contacting said flow-through which comprises small target nucleic acids mixed with a recovery solution with a nucleic acid binding solid phase for binding the contained small target nucleic acids to said nucleic acid binding solid phase, e) optionally performing an elution.Type: ApplicationFiled: September 2, 2011Publication date: June 27, 2013Applicant: QIAGEN GmbHInventors: Vera Holländer, Gabriele Christoffel, Martin Schlumpberger
-
Publication number: 20130115693Abstract: The present invention refers to a device, comprising a hollow body having at least one open end comprising at least one solid matrix binding, adsorbing, absorbing, chelating or retaining compounds which are not desired in a sample and preferably at least one barrier which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force to said barrier, the use of such a device for isolating or purifying a biomolecule from a sample, a method for preparation of said device and a method for isolation or purification of any biomolecule using said device.Type: ApplicationFiled: July 13, 2011Publication date: May 9, 2013Inventors: Vera Holländer, Markus Müller, Karin Schulte
-
Publication number: 20130105393Abstract: The present invention refers to a device, comprising a hollow body having at least one open end and at least one barrier inside or at the end of the hollow body, which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force like pressure, drag force or driving power to said barrier, the use of such a device for collection, storage, treatment or isolation of a biomolecule or biomolecules containing samples, a method for preparation of said device and a method for isolation or purification of any biomolecules using said device.Type: ApplicationFiled: July 13, 2011Publication date: May 2, 2013Applicant: QIAGEN GMBHInventors: Margit Hiesinger, Vera Holländer, Markus Müller, Karin Schulte, Andre Schrader
-
Publication number: 20130053254Abstract: The present invention relates to a process for the parallel isolation and/or purification of RNA and DNA from the same fixed biological sample, the quantification and analysis of the nucleic acids isolated by the process according to the invention, to a kit for the parallel isolation and/or purification of RNA and DNA from a fixed sample and to the use of this kit for the diagnosis, prognosis, decision with respect to therapy and/or the monitoring of the therapy of a disease.Type: ApplicationFiled: February 25, 2011Publication date: February 28, 2013Applicant: QIAGEN GmbHInventor: Vera Holländer
-
Publication number: 20130052721Abstract: The present invention pertains to a method for isolating RNA, including small RNA from a RNA and DNA containing sample, wherein the sample is lysed and the optionally further processed lysate is incubated with a DNase to degrade DNA prior to purifying the RNA from the optionally further processed lysate. It was found that performing the DNase digest prior to isolating the RNA from the lysate has considerable advantages.Type: ApplicationFiled: February 25, 2011Publication date: February 28, 2013Applicant: QIAGEN GmbHInventors: Vera Holländer, Gabriele Christoffel
-
Patent number: 8372637Abstract: The present invention relates to a method of stabilizing a biological sample, having the steps of preparation of a biological sample, and of contacting the biological sample with a composition, having a substance according to the following structural formula: in which R1 is a hydrogen residue or a methyl residue, R2 and R3 are identical or different hydrocarbon residues with a length of the carbon chain of 1-20, and R4 is an oxygen, sulfur or selenium residue (FIG. 1).Type: GrantFiled: May 29, 2008Date of Patent: February 12, 2013Assignee: Qiagen, GmbHInventor: Vera Holländer
-
Publication number: 20110244468Abstract: The present invention relates to a method of isolating/extracting in parallel various biomolecules, in particular nucleic acids and proteins, from the same fixed biological samples, to the quantification and analysis of the biomolecules isolated by the method of the invention, and to a kit for isolating/extracting in parallel various biomolecules from a fixed sample, to the use of said kit for diagnosing, prognosing, deciding the therapy of and monitoring the therapy of a disease.Type: ApplicationFiled: December 4, 2009Publication date: October 6, 2011Applicant: QIAGEN GMBHInventors: Vera Holländer, Peter Porschewski
-
Publication number: 20100291658Abstract: The present invention relates to method of isolating non-protein-containing biomolecules, in particular nucleic acids, characterized in that protein degradation is carried out on a solid phase.Type: ApplicationFiled: July 25, 2008Publication date: November 18, 2010Applicant: QIAGEN GMBHInventors: Vera Holländer, Stefanie Schröer